RxDoctor Payments Data

Jessica Gruber, MD

Dermatology · Saint Louis, MONPI 1295255115

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.2% of the total across 557 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 32 manufacturers reported payments, led by AbbVie at 26.5% of the total.

$10,397in general payments, 2019–2025

Across 557 payments — averaging $18.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Johnson & Johnson$1K
  • Dermavant Sciences, Inc.$663
  • Arcutis Biotherapeutics, Inc.$652
  • Incyte Corporation$527
  • Novartis$476
  • plus $4K from 26 others

What the payments were for

  • Food & beverage$10,00496%
  • Education$3934%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,397 in reported general payments places this provider in the 80th percentile of 263 dermatology providers in Missouri.

See all dermatology providers in Missouri

Medicare billing

Part B allowed, 2024
$100,546
Medicare patients
425
Services billed
1,737

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate80$3,712
Metronidazole24$1,820
Tacrolimus19$1,460
Fluorouracil17$1,119
Ketoconazole70$929
Fluocinonide19$820
Triamcinolone Acetonide90$805
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc27$782
Doxycycline Hyclate40$541
Minoxidil69$500
Mometasone Furoate23$495
Doxycycline Monohydrate11$420
Finasteride32$381
Hydrocortisone49$309
Mupirocin44$220

Paid to pharmacies, not to this prescriber.

Other dermatology in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →